Text Size:
Color Theme:

News Details

Stay informed with the latest corporate announcements, market updates and company news.

3B BlackBio Dx - Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial R

Back

3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the first quarter ended 30th June, 2026.